Cargando…

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease

Angiotensin-Converting Enzyme 2 (ACE2) has been identified as the host receptor for SARS-coronavirus 2 (SARS-CoV-2) which has infected millions world-wide and likely caused hundreds of thousands of deaths. Utilizing transcriptomic data from four cohorts taken from Crohn’s disease (CD) and non-inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Potdar, Alka A., Dube, Shishir, Naito, Takeo, Botwin, Gregory, Haritunians, Talin, Li, Dalin, Yang, Shaohong, Bilsborough, Janine, Denson, Lee A., Daly, Mark, Targan, Stephan R., Fleshner, Phillip, Braun, Jonathan, Kugathasan, Subra, Stappenbeck, Thaddeus S., McGovern, Dermot P.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276052/ https://www.ncbi.nlm.nih.gov/pubmed/32511625 http://dx.doi.org/10.1101/2020.04.19.20070995

Ejemplares similares

Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease
por: Potdar, Alka A., et al.
Publicado: (2021)

Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information
por: Liu, Ruize, et al.
Publicado: (2023)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

Genetic variation in environmental enteropathy and stunting in Zambian children: A pilot genome wide association study using the H3Africa chip
por: Mweetwa, Monica N., et al.
Publicado: (2023)

Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome
por: Jacobs, Jonathan P., et al.
Publicado: (2022)

Association of NOD2 and IL23R with Inflammatory Bowel Disease in Puerto Rico
por: Ballester, Veroushka, et al.
Publicado: (2014)

Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn’s Disease
por: Siegel, Corey A, et al.
Publicado: (2021)

Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study
por: Matzkies, Franziska G, et al.
Publicado: (2012)

Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
por: Li, Dalin, et al.
Publicado: (2021)

Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism
por: Tong, Maomeng, et al.
Publicado: (2014)

Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients
por: Wu, Yiming, et al.
Publicado: (2023)

Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic
por: Melmed, Gil Y., et al.
Publicado: (2021)

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study
por: Wallis, Dinny, et al.
Publicado: (2013)

Pleiotropic ZIP8 A391T implicates abnormal manganese homeostasis in complex human disease
por: Sunuwar, Laxmi, et al.
Publicado: (2020)

Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD
por: Venkateswaran, Suresh, et al.
Publicado: (2018)

Diagnostic and therapeutic potential of RNASET2 in Crohn’s disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion
por: Biener-Ramanujan, Eva, et al.
Publicado: (2022)

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome
por: Schirmer, Melanie, et al.
Publicado: (2018)

The role of admixture in the rare variant contribution to inflammatory bowel disease
por: Astore, Courtney, et al.
Publicado: (2023)

Relationship between the gut and the spine: a pilot study of first-degree relatives of patients with ankylosing spondylitis
por: Kehl, Amy S, et al.
Publicado: (2017)

Diarrhea
por: Kugathasan, Subra
Publicado: (2004)

Viral interactions with the host and microbiota in the intestine
por: Moon, Clara, et al.
Publicado: (2012)

Counteracting stem cell expansion during wound repair: Distinct roles of non-canonical Wnt and TGF-β
por: Miyoshi, Hiroyuki, et al.
Publicado: (2013)

A screen of Crohn’s disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells
por: Chang, Yu-Ling, et al.
Publicado: (2018)

Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD
por: Li, Dalin, et al.
Publicado: (2022)

Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants
por: Venkateswaran, Suresh, et al.
Publicado: (2019)

Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn’s disease
por: Pelia, Ranjit, et al.
Publicado: (2021)

Reply
por: Melmed, Gil, et al.
Publicado: (2021)

IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein
por: Michelsen, Kathrin S., et al.
Publicado: (2009)

Sparse generalized linear model with L(0) approximation for feature selection and prediction with big omics data
por: Liu, Zhenqiu, et al.
Publicado: (2017)

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
por: Siegel, Corey A, et al.
Publicado: (2021)

The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
por: Li, Dalin, et al.
Publicado: (2021)

L-WRN conditioned medium for gastrointestinal epithelial stem cell culture shows replicable batch-to-batch activity levels across multiple research teams
por: VanDussen, Kelli L., et al.
Publicado: (2019)

Organoids in gastrointestinal diseases: from experimental models to clinical translation
por: Günther, Claudia, et al.
Publicado: (2022)

Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor
por: Tran, Deanna Hoang-Yen, et al.
Publicado: (2016)

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
por: Lloyd-Price, Jason, et al.
Publicado: (2019)

Targeted Gene Sequencing in Children with Crohn’s Disease and Their Parents: Implications for Missing Heritability
por: Chen, Jiun-Sheng, et al.
Publicado: (2018)

Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis
por: Moon, Clara, et al.
Publicado: (2013)

IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury
por: Kuhn, Kristine A., et al.
Publicado: (2014)

Altered splicing associated with the pathology of inflammatory bowel disease
por: Berger, Kiera, et al.
Publicado: (2021)

Mucosal microbiome is predictive of pediatric Crohn’s disease across geographic regions in North America
por: Shah, Rajesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmou1inag1hdvq5eujsf69a2rt